| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |